Profil
Philip Ashton-Rickardt was the founder of Smith Therapeutics, Inc. (founded in 2017), where he held the titles of President, CEO, Secretary & Director until 2019.
He is currently the Chief Scientific Officer at Sigilon Therapeutics, Inc. (since 2021).
Previously, he worked as the Chairman of Immunology at Imperial College London, Senior Vice President of Immunology at AZTherapies, Inc. (2019-2021), and Associate Professor at The University of Chicago (1995-2006).
Dr. Ashton-Rickardt obtained his doctorate degree from The University of Edinburgh and his undergraduate degree from King's College London.
Aktiva positioner av Philip Ashton-Rickardt
| Företag | Position | Start |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2021-06-14 |
Tidigare kända positioner av Philip Ashton-Rickardt
| Företag | Position | Slut |
|---|---|---|
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for Alzheimer's disease | Företagsledare/Principal | 2021-06-01 |
Smith Therapeutics, Inc.
Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Grundare | 2019-10-31 |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | 2006-06-01 |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Philip Ashton-Rickardts utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
AZTherapies, Inc.
AZTherapies, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes drugs for Alzheimer's disease | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Edinburgh
The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
King's College London
King's College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics and functional cures for patients with chronic diseases | Health Technology |
Smith Therapeutics, Inc.
Smith Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
















